ClinicalTrials.Veeva

Menu

Characteristics of Peripheral Blood Lymphocyte Subsets in Children With PNS

N

Nanfang Hospital, Southern Medical University

Status

Unknown

Conditions

Lymphocyte Disorder
Nephrotic Syndrome

Study type

Observational

Funder types

Other

Identifiers

NCT05392244
NFEC-2022-076

Details and patient eligibility

About

The etiology and precipitating factors of PNS remain unclear. Dysfunction of immunologic function is a classic theory of the pathogenesis of PNS. This study was aimed at investigating the characteristics of peripheral blood lymphocyte subsets and exploring its value of predicting infection in children with primary nephrotic syndrome (PNS).

Full description

As a common type of nephrosis in children, primary nephrotic syndrome (PNS) is a clinical syndrome characterized by a heavy proteinuria, hypoalbuminemia, edema, and hyperlipidemia, caused by increased plasma protein permeability of the glomerular filtration membrane. To date, the etiology and precipitating factors of PNS remain unclear. Dysfunction of immunologic function is a classic theory of the pathogenesis of PNS, especially dysfunction of lymphocytes and lymphocyte subsets.

Lymphocyte subsets level can reflect human cellular immune function, which performs different biological functions, and coordinate with each other to maintain the body's immune function homeostasis. At present, many studies have shown that abnormal cellular immune function is closely related to the pathogenesis of PNS in children. Compared with children with PNS with mild proteinuria, CD8+ T cells were significantly increased in children with large proteinuria, and CD4+ T cells were reduced compared with healthy children and children with stable phase. NK cells are also considered to be an indicator that can assess the prognosis of children with PNS. Abnormal number or function of Regulatory T cells (Treg) may be involved in the occurrence of PNS proteinuria, and the urine protein level of the rat model can be relieved by the increase of Treg cells. Although studies have found abnormalities in the lymphocyte subsets of children with PNS, these conclusions are not consistent, indicating that the relationship between cellular immunity and the pathogenesis of children with PNS remains to be studied.

Children with PNS are susceptible to various of infections. After the application of glucocorticoids, children with PNS are more susceptible to infection, even if the infection is not serious, which can lead to recurrence of PNS or affect the curative efficacy of treatment. Studies have found that corticosteroid therapy affects the distribution of lymphocyte subsets in children with PNS, and changes in the level of CD4+ T cells are related to the occurrence and severity of infection in children with NS. The above studies all indicate that lymphocyte subsets analysis has important research significance in the occurrence and prevention of infections in children with PNS.

In this study, we observed the profiles of peripheral blood lymphocyte subsets in healthy children and children with PNS, and explored the risk factor of infection in children with PNS.

Enrollment

100 estimated patients

Sex

All

Ages

Under 18 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age <18 years old
  • first PNS episode or PNS in remission
  • no history of corticosteroid or immunosuppressor use in the four weeks prior to disease occurrence

Exclusion criteria

  • Subjects with infantile (or congenital) nephrotic syndrome (NS), secondary NS, glomerulonephritis, or systemic disease were excluded.

Trial design

100 participants in 3 patient groups

active group
Description:
Active PNS was defined as a serum albumin concentration of \<2.5 g/dL and a urinary protein excretion of \>40 mg/m2 per hour with high cholesterol levels.
partial remission group
Description:
Partial remission PNS was defined as symptoms between active group and complete remission group.
complete remission group
Description:
PNS in remission was defined as no proteinuria using the colorimetric qualitative test and a urinary protein/creatinine ratio of \<0.2 on a random urine sample.

Trial contacts and locations

0

Loading...

Central trial contact

Shuai Chu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems